Category Archives: Meso Cancer

2017 Stop-Cancer! World Awareness Day: February 4th

World Cancer Cure DaY

Dear Cancer Research Supporter:

Every year the world comes together to fight cancer on February 4th — World Cancer Day!

This is a chance to raise worldly awareness; encourage cancer cure education; and promote among our community the research for a cure to the deadly disease called Mesothelioma Cancer.

Hi! I’m Dr. Parkash Gill, professor of Medicine and Pathology at the Keck School of Medicine of USC; head of the tumor and vascular biology laboratory at the University of Southern California; the Leader of the Translational and Clinical Sciences Program at the USC Norris Comprehensive Cancer Center, and the Ezalow Family Chair in Cancer Therapeutics.

My focus, and that of the research team with me, is on the future of mesothelioma cancer care — and I’m fortunate enough to benefit from funds provided by the Mesothelioma Research Foundation of America. Their funds help me, and the young scientists working with me, to explore promising new approaches and technologies to treat mesothelioma cancer.

My work is in the emerging field called: Targeted Cancer Therapy (TCT). Targeted therapy is a cancer treatment that uses drugs, however, it is different from traditional chemotherapy. The drugs known as targeted therapy help stop cancer from growing and spreading. They work by targeting specific genes or proteins. These genes and proteins are found in cancer cells or in cells related to cancer growth, like blood vessel cells.

My hope is that Trials for TCT research will be a standard part of the options offered on every mesothelioma cancer patient’s treatment plan. Certified clinicians will use TCT models to plan the best care, and select the most effective drug treatment for each person’s individual disease, translating to fewer side-effects upon the patient; the patient spends less time in treatment; and more patients have better results.

My research team and I are looking forward to where our studies take us, thanks to the extraordinary funding and support from Mesothelioma Research Foundation of America. If you would like to discover more about Targeted Cancer Therapy and the hope it holds for the future of mesothelioma cancer care, please check out our World Cancer Day page at www.MesoRFA.org and use the form to contact us!

Best regards,

Dr. Parkash Gill, Oncologist

Money Goes to Effective, Ongoing Cancer Research and Treatment

DISTRICT COUNCIL 16 GIVES $200,000 FOR CANCER RESEARCH

Money Goes to Effective,
Ongoing Cancer Research and Treatment

By Robert Buscemi

The United Association Southern California Pipe Trades Council 16 presented the Mesothelioma Research Foundation of America with a check for $200,000 at the Council’s annual holiday lunch.

2015-02-district-16-donation
DC 16 gives a landmark amount to a worthy cause: (l-r) Shane Rucker, Dr. Parkash Gill, Elizabeth Paul, Jerry Neil Paul and John Ferruccio.

The money, all raised in 2014, will go toward a cure for mesothelioma, a cancer caused by exposure to asbestos. District Council 16 Director of Organizing John Ferruccio emceed the event December 12 at the Dodger Stadium Club. He held off announcing the impressive dollar figure until after the speeches, when a drum roll from the house band built the excitement.

“Every year, as you know, one of our main fundraisers is to find a cure for this unfortunate disease,” Ferruccio told more than 150 attendees. “Mostly, mesothelioma is affecting our grandfathers, fathers and fathers-in-law. It’s gotten a lot better over the years.”

Ferruccio said the Council hosts an annual golf tournament and skeet-shooting events. In addition, the State Building and Construction Trade Council of California raises money through the annual Roger Hamilton golf invitational.

The foundation, known as MESORFA, was founded in 2001 by attorney Jerry Neil Paul, his wife Elizabeth Ann Paul and retired California Pipe Trades Representative and past Vice President of the State Building and Construction Trade Council, Jim Kellogg.

2015-02-district-16-donation-elizabeth-paul
“To bring a treatment to the public costs tens of millions of dollars,” Elizabeth Paul tells the crowd.

In thanking District Council 16, MESORFA Executive Director Elizabeth Paul explained that all funding goes toward research rather than administration.

“All of this money goes directly to fund a lab at USC Norris Comprehensive Cancer Center here in Los Angeles. We use 100 percent of every dollar donated toward research, for clinical trials and to fund the lab. Nothing goes for the foundation – those costs are privately underwritten.”

Cancer Research Costs Millions

Paul said such research is never cheap, and other cancers get more attention and funding than mesothelioma, especially in a tight economy. Indeed, she said, MESORFA operates on a shoestring budget. “I know people don’t understand that, but to bring a treatment to the public costs tens of millions of dollars.”

As such, Paul said District Council 16’s annual contribution is crucial.

“Everybody was extremely generous. Families took care of families. My husband Jerry and I are big on family. Your leaders at District Council 16 view your members as family. Because they have gone out of their way to make sure that there are treatments and cures for this horrible disease.”

The disease hits especially hard at workers who have been exposed to asbestos, as many Pipe Trades and other Building Trades were before protections were put in place against the toxic substance. Even now, workers confront the hazard at some job sites.

Paul then introduced Dr. Parkash Gill, who reported that he has made huge strides at his lab through the development of Veglin, a drug that treats the disease.

“I’m honored to be part of it,” Gill said. “It’s a worthy cause. I’m a cancer research doctor, so finding a treatment for patients really is a rewarding experience. When somebody is ill and they get better and they go home and never see you again, it’s wonderful.”

Gill said that patients are already seeing positive results at treatment advances. He said certain efforts have been completely successful.

“This medicine, we have given to a 78-year-old patient. Two or three years out now, there’s no cancer left and no side effects.”

Study Shows Asbestos Bans are Slow to Reduce Malignant Mesothelioma Rates

It has been more than 32 years since Denmark began in 1972 a ban on the use of asbestos insulation. In the late 1980s, Denmark also extended its ban to include other products containing asbestos.  And now, Denmark is one of 55 countries who have completely banned asbestos  products.  

But according to the new study of mesothelioma in Denmark, a steady rise in cases of this asbestos-linked cancer that began in the 1950s is still going on.

Mesothelioma and Asbestos

Mesothelioma is an aggressive cancer of the membranes around internal organs, most often the lungs or abdomen of the patient. It is a deadly disease that comes from exposure to the mineral asbestos.

Asbestos was made into a popular insulator and component in building materials worldwide back in the 1930s because it was readily available, cost little, and its very resistant to fire and corrosion.  The use of Asbestos in the building materials has put hundreds of thousands of workers at risk for mesothelioma.

Many countries, including Denmark, began in the 1950s and 60s to reduce their use of Asbestos products after it was linked to mesothelioma cancer as well as other unhealthy conditions.Pleural Mesothelioma Asbestos Lung Cancer

In a Danish study, the research team used data from the years 1943 through 2009 about mesothelioma stored at the Danish Cancer Registry. The researchers discovered the total incidence of mesothelioma continued to rise throughout the study period showing a peak of 1.76 cases per 100,000 people during the years 2008-2009.

The study also identified more cases in the Region of Northern Jutland in comparison to Southern Denmark.  While mesothelioma survival rate has improved slightly, the researchers noted that the  prognosis for getting mesothelioma continues to remain poor based on a median rate of 12.5 months survival for men and 13.3 months survival for women in the years 2008 through 2009.

In the Danish Medical Journal, the authors conclude:

“The national malignant mesothelioma incidence for men continues to increase, perhaps showing a slight tendency towards deceleration in the most recent decade,”

But they go on to say that:

“A clear long-term effect of the Danish asbestos ban has not yet occurred.”

Lag Time between Asbestos Exposure and Mesothelioma Diagnosis

With mesothelioma, the lag time  (latency period) between exposure to asbestos  and the development of the disease can be many decades.   It is during the latency period that the disease is very difficult to detect and diagnose, much less tracing its source.  Frequently mesothelioma cancer is diagnosed late in its development, and it tends to progress quickly.  Estimates from the World Health Organization show that since 1994, more than 92,000 people have died from mesothelioma cancer.

RESULTS:

In Denmark, the national incidence of malignant mesothelioma cancer for men has been rising during the study period, reaching its total maximum of 1.76 in 2008-2009.  The incidence rate has remained relatively steady for women with a maximum of 0.5 in 1973 through 1977.

Northern Jutland and the surrounding region records the highest male incidence rate of mesothelioma since the late 1980s. The difference in relative risk for men in the Region of Southern Denmark and the Region of Northern Jutland was 1.53 during the period of 2008-2009.  The relative risk of developing mesothelioma cancer in the Region of Northern Jutland for the entire study period when collectively compared to the whole of Denmark was 1.38.  The study showed there are no notable regional differences for women at risk of developing mesothelioma.  Therefore, survival has slightly improved for both genders, but still remains poor with a median survival of 12.5 months for men and 13.3 months for women in the period of 2008 through 2009.

CONCLUSION:

Within Denmark the national malignant mesothelioma incidence for men continues to increase, perhaps showing a slight tendency towards deceleration in the most recent decade. A measurable long-term mitigating effect of the Danish ban on asbestos products  has not yet occurred.

The original Danish study appeared in the Danish Medical Journal. (Skammeritz, E, et al, “Regional difference in incidence of malignant mesothelioma in Denmark“, March 2013, Danish Medical Journal.

http://www.ncbi.nlm.nih.gov/pubmed/23484611

The Mesothelioma Research Foundation of America has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Related Mesothelioma Cancer Press Releases

Possible New Treatment for Mesothelioma with MicroRNA Research

Today’s cancer cure researcher will frequently dig deep into the genetic makeup of the cancer disease to understand how it grows.  While in search for the most effective treatment to cure lung cancer and mesothelioma, and by genetically figuring that out, the researcher can stop the aggressive cancers by halting its growth.  Currently, Oncologists believe that a pair of microRNAs should be focused on for suppressing tumor growth in lung cancer.microRNA genetic research mesothelioma

microRNAs, or miRNAs, are tiny molecules found within cells that serve a function in primary biological processes.  These processes include organ development, fat metabolism, and cell proliferation.  A person remains healthy when miRNAs are functioning properly.  And, miRNAs can inhibit tumor growth when used as a therapeutic agent.

While miRFAs let-7 and miR-34 are known to be effective individually at stopping cancer growth, researchers at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) found that by combining these two molecules the pair are even more effective.

MicroRNA and Lung Cancer

Specifically, the miRNAs were unleashed on cancer pathways RAS and p53, two oncogenes, genes that have the potential to transform a cell into a cancer cell, known to lead to the aggressive growth of non-small cell lung cancer (NSCLC).  The resulting two-molecule agent was found to be safe and effective in a lung cancer mouse model and demonstrated efficacy showing survival advantage.

According to one of the authors, Frank Slack, PhD (Director of the Institute for RNA Medicine in BIDMC):   “We know that miRNAs target many oncogenes.  We, therefore, hypothesized that a combination of two miRNAs could similarly offset resistance.  We have performed these timely in vivo studies using a liposomal microRNA delivery agent already in clinical trials, which could accelerate the translation of this combinatorial miRNA therapeutic approach into the clinic.”

Dr. Slack also said that currently there are no approved drugs that are effective for patients with RAS and p53 mutations. He mentioned reports that the K-RAS mutation is found in 25 percent of NSCLC patients while 50 percent are affected by the p53 mutation.

Pleural Mesothelioma

Pleural mesothelioma, an asbestos-caused cancer equally as aggressive as NSCLC, is diagnosed in close to 3,000 Americans each year.  And while microRNA research is focused on lung cancer, every new breakthrough in lung cancer research also brings new hope to patients with mesothelioma cancer.

The study was published in the Sept. 1 issue of Oncogene.

Computed Tomography Screening for Mesothelioma Finds Asbestos-Related Lung Disease, According to Surviving Mesothelioma

Recent Tomography Research for Mesothelioma

The original study is published in the Journal of Computer Assisted Tomography (Carrillo, MC, et al, Low-Dose Computed Tomography (LDCT) in Workers Previously Exposed to Asbestos: Detection of parenchymal Lung Disease, July-August, 2013, Journal of Computer Assisted Tomography, pp. 626-630).

Recent research study reports that a lower dose of the same technology often used to diagnose mesothelioma may be able to help identify other asbestos-related lung diseases in people at risk for the deadly cancer.Tomography and Mesothelioma

Tomography in Canada for Mesothelioma

A study in Canada states that it tested the value of Low-Dose Computed Tomography (LDCT) for lung disease in asbestos-exposed workers.  The individuals were being screened for lung cancer or mesothelioma.  The Canadian research study focused on 315 baseline LDCT examinations of the chests of participants with at least 20 years of exposure to asbestos. Also included in the analysis were people who were found to have pleural plaques on X-ray (these are areas of calcification on the lung lining caused by asbestos).

The average age of the study participants was just under 62. All had been exposed to asbestos in an occupational setting for an average of 26.9 years. Forty-four percent of participants (140 people) had what were called parenchymal findings, or evidence of abnormalities in their lung tissue. Although such parenchymal findings do not necessarily indicate the presence of lung cancer or mesothelioma, they can be early evidence of a developing problem.

Study participants with parenchymal findings were like patients with mesothelioma in that they tended to be older (average age of 65.3) and have longer-than-average asbestos exposure (average of 29.73 years).  While many participants were also smokers, there was no statistical difference in parenchymal findings between those who smoked and those who did not.

The study concluded that LDCT can be a valuable way to detect early signs of lung disease in people who have no symptoms but are considered at high risk. Like lung cancer and mesothelioma, parenchymal lung diseases are most treatable when detected early. Unfortunately, mesothelioma is almost never found early because it tends not to produce any noticeable symptoms until it is in its later stages.

Because asbestos is the only known cause of mesothelioma, some have suggested the LDCT should be a regular part of health maintenance for all asbestos workers. The current study is further evidence of the value of the technology. Although mesothelioma is often treatment-resistant, it is more responsive to therapy before it has spread beyond the pleural lining and invaded the lungs or lymph nodes.

More Mesothelioma Cancer Press Releases

Second Round of Chemotherapy May Not Help

According to a study by Turkish researchers, a second round of chemotherapy may not do much good for mesothelioma patients whose cancer returns after first-line treatment.

Chemotherapy CRS-207 mesothelioma vaccinationTheir findings are based on an analysis of 51 pleural mesothelioma patients from a Turkish hospital. All patients in the study were initially treated with chemotherapy, the standard first-line treatment for mesothelioma. But, when their mesothelioma tumors began to grow again several months later, some patients were treated with second-line chemotherapy (SLCT) while others had best supportive care (BSC), which includes symptom management only.

Chemotherapy Standard Is Tough

While chemotherapy is a standard first-line treatment for mesothelioma, an aggressive cancer of the mesothelial membranes, there is disagreement within the medical community as to whether or not second-line chemotherapy is effective. While it can sometimes slow the progression of mesothelioma, chemotherapy is also hard on the body and causes a range of dangerous side effects. For this reason, only the healthiest patients are even considered candidates for second-line chemotherapy.

Chemotherapy Survival Rates

In the Turkish study, patients who had chemotherapy as both a first- and second-line treatment had a median overall survival of 20.3 months. These patients had a median survival of 5.9 months after the end of their first-line chemotherapy. Patients who had only BSC when their mesothelioma began to grow again had a median overall survival of 14.7 months. The median overall survival for these patients from the end of their first-line chemotherapy treatment was 4.7 months.

While the figures seem to show that the second-line chemotherapy patients had better outcomes than those receiving BSC, the authors of the study say the differences between the two are not statistically significant. In addition, the fact that second-line chemotherapy is usually reserved for select patients may also contribute to the apparent skew of the results. They conclude, Our results do not support the proposal that second-line chemotherapy could be effective in patients with malignant pleural mesothelioma.”

While such studies can help guide mesothelioma treatment planning, treatment decisions are made on a case-by-case basis, based on a range of criteria. The original study appears in the Asian Pacific Journal for Cancer Prevention. (Mutlu, H, et al,
Secondline chemotherapy versus best supportive care in patients with malignant pleural mesothelioma: a retrospective study
2013
Asian Pacific Journal of Cancer Prevention
pp. 3887-3889
http://www.apocpcontrol.org/page/apjcp_issues_view.php?no=4654&gubun=p&s_search=mesothelioma&s_paper_vol=14&s_number33=6

Useful Mesothelioma Information To Know

Mesothelioma is a rare form tumor cancer.  It refers to the cancerous tumor which primarily involves the mesothelial cells of the human organs, usually abdominal organs or lungs. Since most mesothelioma cancer cases are unsuccessful, it is just important to know some mesothelioma information to make sure you are not afflicted with this threatening disease.

Pleural mesothelioma is the common type of mesothelioma disease . This mesothelioma cancer strikes the pleura which is the membrane between the lungs and the chest cavity.  A lubricated surface to prevent the lungs from chaffing against the chest walls is provided by the membrane.  So, a pleural mesothelioma attack is also known as lung cancer.

Another form of mesothelioma cancer that frequently occurs is called  peritoneal mesothelioma. This cancer afflicts the peritoneum membrane which  encloses the abdomen organs.  Although peritoneal mesothelioma does not  occur as commonly as Pleural mesothelioma, it does tends to be more threatening and invasive.  Therefore, this may result in a shorter life period for the patient.

Mesothelioma Information – Brief History

Where does mesothelioma come from?  This is the most common question asked by persons diagnosed with mesothelioma.  The most common short  answer: exposure to airborne asbestos particles.  When a person is diagnosed this disease,  the cancer’s onset is usually found to be related to a history of asbestos exposure. Asbestos is a mineral, mined and used for many decades as a main thermal insulation material.  Since the 1920’s, it has been widely known that asbestos is a carcinogen, which can cause cancer. Still, asbestos continued to be used in many products until the early part of 1970, and consequently is found currently in many buildings today.60,000 die of asbestos mesothelioma

A unique feature of various asbestos caused diseases is that they have a long latency period.  In other words, from the day of exposure to asbestos fibers and breathing the asbestos dust and the noticeable onset of the cancerous disease can take many years.  A common latency period for mesothelioma cancer can be 20 to 50 years, and sometimes more time.  Therefore, a person can be exposed to asbestos many years ago and only now begin to show the development and signs of mesothelioma.

Clinical Signs and Symptoms of Mesothelioma

With mesothelioma, the signs and symptoms for this cancer can be very general, and unfortunately doctors have misdiagnosed and often neglected and ignored the signs.  In many cases, the signs and symptoms for this cancer type arise between 2 and 3 months before the cancer is fully diagnosed.

Making decisions about what to do with mesothelioma cancer is greatly dependent upon which stage the tumor is at upon discovery.  When you have an early diagnosis of mesothelioma than surgical intervention can sometimes prolong life expectancy.  Depending on the patient’s physical condition and age, the option for surgery may not be possible.  In addition to the option for surgery, then chemotherapy and radiation treatment may be useful in the treatment of mesothelioma.  Finally, home care and pain reduction options are common alternatives and considerations during the later stages of mesothelioma cancer before death.

Where To Go After A Diagnosis with Mesothelioma?

When a person has been diagnosed with mesothelioma, it becomes most important to understand and know the medical treatment options available for the patient.  Always contact and ask questions with an oncologist, or at least your personal doctor so they can provide you with information about mesothelioma as well as some treatment options to choose from.

If you need to speak with an oncologist, Dr. Gill with the Mesothelioma Research Foundation of America welcomes your questions and will gladly provide answers for free.  Simply click on this link and use this contact form to send the doctor your concern.

Mesothelioma Cancer – The Latest News

Mesothelioma kills life-long criminal and infamous author

James Fogle stole his first car at the young age of 12 and set a course for the remainder of his life that would consist of an endless string of crimes.  James, who contracted mesothelioma, spent most of his life living in a prison, and eventually died living behind bars at the age of 75 in August, 2012 probably from the malignant mesothelioma he got while working as a pipe fitter.

Fogle described himself as a restless child born in a small town in Wisconsin and lived with an abusive father.  Early in his youth, he decided that stealing cars would be a form of escapism.  Consequently, James would spend much of his life as a youth in juvenile correctional facilities.  According to his autobiographies, it was in these facilities where he learned methods from other criminal detainees on how to pull off various crimes.  As he sustained his life path of criminal behavior, after serving time in jail as an adult and learning from fellow inmates, upon his release he began robbing drugstores.  James Fogle, all his life, was in and out of prison and seldom experienced freedom for more than a year between sentence terms.James Fogle dies of mesothelioma while living in prison

During one of his prison terms, he was trained to be a steam pipe fitter.  It is suspected that during this era of his life he was exposed to asbestos, which later led to his development of mesothelioma.  When one is  exposed to asbestos fibers, some of the fibers floating in the are you breath can become trapped in the lungs when inhaled, and this can cause the deadly diseases known as mesothelioma.  Mesothelioma lung cancer is caused by exposure to floating asbestos particles.  However, with mesothelioma there is usually a latency period of 20 to 50 years from the time of exposure before the development of symptoms can be recognized.

Mesothelioma diagnosis typically begins with a sufferer’s visit to the doctor complaining of chronic chest pain. This pain is caused as a result of a buildup of fluid inside the pleural space; this is called pleural effusion and is the most common presenting symptom of malignant mesothelioma.

Preliminary mesothelioma detection can be achieved through a chest imagery scan (CT scan, x-ray); however, mesothelioma is often misdiagnosed as viral pneumonia at this stage because of certain symptomatic similarities between the two. The only way to definitively verify a suspected case of malignant mesothelioma is through a biopsy.

Because of his mesothelioma cancer condition and toward the end of his life, James was required to use an oxygen tank to breathe.

Mesothelioma kills book writer

While James  only had a sixth-grade education, he became inspired by books he read during his prison time.  From his reading he developed his own writing style, and wrote 11 autobiographical novels while doing his time.   “Drugstore Cowboy,” is the story about drug addicts who teamed up to support their drug addictions by working together to  rob  pharmacies.  This was the only book he wrote that got published.  This novel was used to create a highly-regarded and  successful film by director Gus Van Sant.  The film was made in 1989 with Matt Dillon playing the lead role.  William Burroughs, one of the major faces of the Beat Generation, had a minor role in the movie, and lauded Fogle’s novel.

At the Monroe Correctional Complex in Monroe, Washington, James Fogle was serving out his 16-year sentence for  crimes committed when he died of mesothelioma cancer.

References:

http://www.nytimes.com/2012/08/30/us/james-fogle-author-of-drugstore-cowboy-dies-at-75.html

http://articles.latimes.com/2012/aug/26/local/la-me-james-fogle-20120826

http://seattletimes.com/html/obituaries/2018979541_cowboy24m.html

How Mesothelioma Might Impact Long Term Health

Mesothelioma Diagnosis

While it might seem that a diagnosis is the most important part of mesothelioma and handling your health, this is far from the case. The diagnosis is merely the starting point from which you need to begin treatment. And though your health might be something you consider to be priceless, it is also something which can be very expensive when it comes to managing mesothelioma. This is why those with mesothelioma seek legal restitution for their injuries. Though your initial diagnosis can be traumatic, the bills which come from your long term care can be catastrophic without the financial help you deserve from an employer.

Mesothelioma is a Cancer

malignant mesothelioma xrayAs one of the rarest forms of cancer, mesothelioma is a condition which impacts not only the lungs, but the entire body as well. A cancer is a condition in which cells are damaged at the DNA level and then when they replicate, the cells are then damaged, causing pain, illness, and tumors. If the cells can be destroyed via radiation, chemotherapy, or other treatments, the cancer can be cured. But as mesothelioma tends to spread in the body before it is detected, it can be difficult to cure this cancer without using a combination of treatments, all of which may not completely remove the cancer from the body.

Radiation and Chemotherapy for Mesothelioma

In order to stop the spread of mesothelioma in the body, most doctors will prescribe radiation and chemotherapy treatments. While these can be wildly successful, they can also be very difficult to manage in some patients. As every patient is different and every cancer is different, you may find that your mesothelioma doesn’t respond to one treatment, but does respond to another – and of course that is the treatment which is not covered by your insurance policy. Each radiation and chemotherapy treatment can cost thousands of dollars and they need to be given regularly in order to provide the results you and your mesothelioma need.

Surgery and Combination Treatments

Sometimes, the only thing which can be done to help mesothelioma is to remove the tumors which are spreading in the body. This is painful, extensive, and possibly even debilitating if there are enough tumors which need to be removed. With the proper financial compensation for mesothelioma, you will be able to not only pay for the surgeries and their related costs, but you will also be able to pay for the pre- and post- care needs. You will be able to also have follow-up surgeries if the mesothelioma proves to be difficult to manage.

More Mesothelioma Articles

North Ireland Deaths From Mesothelioma and Asbestosis in 2012

Asbestosis Big Problem in Northern Ireland

Asbestosis Lung

 

The Northern Ireland General Register Office, the province’s record keeper, said that mesothelioma and asbestosis were the primary or secondary causes of some 75 deaths annually.

In little more than five years, there have been more than 300 estimated deaths in Northern Ireland from asbestos exposure, according to a U.TV article, citing a recent government report.

This government report also suggests  there were possibly another 40 lung cancer deaths each year where asbestosis or mesothelioma were contributing factors.  Mesothelioma is a rare and deadly disease that destroys the linings of the heart, lungs or abdomen.  Exposure to asbestos is nearly always the cause of mesothelioma.  And asbestosis is specifically a lung disease caused by inhaling asbestos.

The situation is serious were unlike the United States which phased out asbestos in building materials in the 1980s, asbestos continued to be used in Northern Ireland until about 2000. The Health and Safety Executive for Northern Ireland (HSENI) organization predicts the current number of deaths to rise.  It has organized free training called “Asbestos Training Pledge NI” as a response to help local construction workers protect themselves from asbestos exposure.

Asbestos is a fibrous mineral once used extensively in building materials because of its high tensile strength, durability, high availability, and low cost.   Given its’ early widespread adoption in the United States, asbestos continues to be a problem there as well.  Since the 1970s,  research has linked asbestos exposure definitively to multiple painful and deadly diseases, such as mesothelioma.

Many manufacturers knew their asbestos products posed serious health risks, but some hid this information from both their workers and the public. Have you or a loved one developed mesothelioma after exposure to asbestos while at a workplace?  If so, then call a Lawyer who is an expert in Mesothelioma and Asbestosis, and ask them for a free legal consultation about a potential mesothelioma lawsuit.

More Mesothelioma and Asbestosis Information